Dermatologic Disease of Inpatients in Internal Medicine Clinical Trial
This is a 3 months single centre clinical patient-oriented study to evaluate the prevalence
and impairment in QOL of dermatologic diseases in patients hospitalised in internal
medicine.
Up to 200 patients hospitalised at the division of internal medicine for any reason are
going to be offered participation by a patient information form given to patients at the
time of admission, as well as oral information about the study. Written informed consent
will be obtained by the investigators after patients have had adequate time to consider
their participation in the study.
Participating patients will be examined clinically for dermatologic pathologies at a single
visit. In the case of signs of dermatologic disease, investigators are going to recommend
further diagnostic procedures to the physician in charge and/or the referring physician,
depending on the urgency of the suspected diagnosis. This procedure is meant to avoid giving
referring physicians the impression that active patient acquisition for the department of
Dermatology is an aim of this study. Diagnostic procedures that are performed upon suspicion
of a specific dermatologic disease at the Division of Internal Medicine are going to be
performed during the hospitalisation period. All other diagnostic or operative procedures
are going to be advised to the referring physician.
Study participants are going to be interviewed by the investigators about impairment in QOL
of their illnesses. Two separate questionnaires are going to be filled in by each
participant. For measurement of general QOL, the widely used SF-12 questionnaire (8
questions) is going to be used. To measure specific impairment in QOL by dermatologic
disease, participants are going to be asked to fill in the DLQI (Dermatology life quality
index, 10 questions). Photographic documentation of specific identified lesions will be made
and pictures stored exclusively in the secured electronic patient file (KISIM). Medication
and all identified diseases will be noted. All diagnostically useful information is going to
be recorded in the patient file and transmitted to the referring physician in the discharge
letter.
n/a
Time Perspective: Prospective